Menstrual irregularity,pregnancy outcomes,and birth outcomes in patients with systemic lupus erythematosus of childbearing age in China:a multicenter cross-sectional study  

作　　者：Yuke Hou Jiayang Jin Liang Luo Yuchao Zhong Zhe Peng Ziyi Song Chun Li Xuewu Zhang 

机构地区：[1]Department of Rheumatology and Immunology,Peking University People’s Hospital,Beijing 100044,China [2]Department of Chinese Medicine,Chongqing Yubei People’s Hospital,Chongqing 401120,China [3]Department of Rheumatology and Immunology,Peking University Shenzhen Hospital,Shenzhen,Guangdong 518036,China [4]Center of Reproductive Medicine,Peking University People’s Hospital,Beijing 100044,China

出　　处：《Chinese Medical Journal》2023年第23期2886-2888,共3页中华医学杂志（英文版）

基　　金：Beijing Natural Science Foundation(No.7192211);China International Medical Foundation(No.Z-2018-40-2101)

摘　　要：To the Editor:Systemic lupus erythematosus(SLE)is an autoimmune disease that tends to affect females of childbearing age.There are nearly 4 million people in China currently suffering from SLE,which can cause multiple organ damage in its early stages and seriously affect patients’quality of life.[1-3]Menstrual disorders are common in SLE patients and vary from heavy menstrual bleeding to amenorrhea.The etiology of menstrual irregularities includes the disease activity itself,glucocorticoids(GCs)treatment,and the use of some immunosuppressants.[4]This multicenter,cross-sectional,web-based observational study investigated menstrual irregularity,pregnancy outcomes,and birth outcomes on SLE patients across China.The research was approved by the Ethics Committee of Peking University People’s Hospital,China(No.2019PHB253-01).The patients were informed that consent was implied with completion of the questionnaire,and the process was anonymous and voluntary.

关 键 词：PATIENTS sectional BIRTH 

分 类 号：R714.2[医药卫生—妇产科学]